RankAlpha logo
Back to Rankings

HITI

High TideD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
HITI vs peer average
39/100
HITI vs. peer average (D vs. C)
Grade spread
A 1 · B 1 · C 2 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

RNA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $209.54M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRNAAtrium Therapeutics
HITI
High Tide
RNA
Atrium Therapeutics
Grade
D
D
Momentum
16
28
Value
65
57
Sentiment
-
51
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs RNA

HITI / RNA
Grade Position
Below peers
HITI vs. peer average (D vs. C)
39/100
Momentum
16
RNA
Value
65
HITI
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HITI
1
RNA
Atrium Therapeutics Inc Common
D
40/100
Even
2
FULC
Fulcrum Therapeutics Inc Common
F
20/100
+1
3
KPTI
Karyopharm Therapeutics Inc Common
B
80/100
-2
4
KROS
Keros Therapeutics Inc Common
C
60/100
-1
5
NKTX
Nkarta Inc Common
A
100/100
-3
RNA is the first peer returned for this comparison set.